GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intervacc AB (OSTO:IVACC) » Definitions » Institutional Ownership

Intervacc AB (OSTO:IVACC) Institutional Ownership : 11.67% (As of Jun. 14, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Intervacc AB Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Intervacc AB's institutional ownership is 11.67%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Intervacc AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Intervacc AB's Float Percentage Of Total Shares Outstanding is 0.00%.


Intervacc AB Institutional Ownership Historical Data

The historical data trend for Intervacc AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intervacc AB Institutional Ownership Chart

Intervacc AB Historical Data

The historical data trend for Intervacc AB can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 15.81 15.10 14.31 12.99 12.50 11.67 11.67 11.67 11.67 11.67

Intervacc AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Intervacc AB (OSTO:IVACC) Business Description

Traded in Other Exchanges
Address
Vastertorpsvagen 135, Hagersten, Stockholm, SWE, S-129 44
Intervacc AB is a biotechnology company. It develops new vaccines based on recombinant proteins to meet the increasing need for effective vaccines in animal health care. The company through its subsidiary focuses on diagnostics in the Swedish animal health market and offers bacteriological and mycological analyses on the Swedish market.

Intervacc AB (OSTO:IVACC) Headlines

No Headlines